Funding
NCI-CCSG, Cancer
CANCER
This study was sponsored by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. Services, results, and/or products in support of the research project were generated by the Rutgers Cancer Institute of New Jersey Immune Monitoring Shared Resource, supported, in part, with funding from the NCI-CCSG P30CA072770-5920. Additionally, this research was supported in part by Gateway for Cancer Research (G-16-800).